Get Live Data

GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
GreenRoc Accelerates their World Class Project to Production as Early as 2028
GreenRoc Accelerates their World Class Project to Production as Early as 2028View Video

Latest Share Chat

  2. Share Prices
  3. Ekf Diagnostics Share Price
  4. Ekf Diagnostics Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksEkf Diagnostics Share News (EKF)

Ekf Diagnostics Information

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.40
Bid: 29.20
Ask: 29.90
Change: -0.35 (-1.18%)
Spread: 0.70 (2.397%)
Open: 29.50
High: 30.00
Low: 29.40
Prev. Close: 29.75
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Tue, 23rd Mar 2021 16:07

Wednesday 24 March 
Softcat PLCHalf Year Results
Circassia Group PLCFull Year Results
Burford Capital LtdFull Year Results
Sopheon PLCFull Year Results
Strix Group PLCFull Year Results
TClarke PLCFull Year Results
Keywords Studios PLCFull Year Results
ECSC Group PLCFull Year Results
Telit Communications PLCFull Year Results
Bellway PLCHalf Year Results
Diploma PLCTrading Statement
Anglo Pacific Group PLCFull Year Results
Frontier IP Group PLCHalf Year Results
Pendragon PLCFull Year Results
Applied Graphene Materials PLCHalf Year Results
Kenmare Resources PLCFull Year Results
Thursday 25 March 
Allied Minds PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Biome Technologies PLCFull Year Results
Cineworld Group PLCFull Year Results
Compass Group PLCTrading Statement
CVS Group PLCHalf Year Results
EnQuest PLCFull Year Results
Equiniti Group PLCFull Year Results
Faron Pharmaceuticals OyFull Year Results
Funding Circle Holdings PLCFull Year Results
Genedrive PLCHalf Year Results
International Public Partnerships LtdFull Year Results
IQE PLCFull Year Results
Lamprell PLCFull Year Results
Learning Technologies Group PLCFull Year Results
Pebble Group PLCFull Year Results
Robinson PLCFull Year Results
S4 Capital PLCFull Year Results
Safestyle UK PLCFull Year Results
SIG PLCFull Year Results
Surgical Innovations Group PLCFull Year Results
United Utilities Group PLCTrading Statement
Friday 26 March 
Smiths Group PLCHalf Year Results
Monday 29 March 
Quixant PLCFull Year Results
Brighton Pier Group PLCHalf Year Results
Dev Clever Holdings PLCFull Year Results
Ten Entertainment Group PLCFull Year Results
Impact Healthcare REIT PLCFull Year Results
Tuesday 30 March 
S&U PLCFull Year Results
Nanoco Group PLCHalf Year Results
Michelmersh Brick Holdings PLCFull Year Results
Dialight PLCFull Year Results
AG Barr PLCFull Year Results
K3 Business Technology Group PLCFull Year Results
Silence Therapeutics PLCFull Year Results
EKF Diagnostics Holdings PLCFull Year Results
Real Estate Investors PLCFull Year Results
Bowleven PLCHalf Year Results
Pennon Group PLCTrading Statement
Central Asia Metals PLCFull Year Results
Chesnara PLCFull Year Results
Yu Group PLCFull Year Results
Mpac Group PLCFull Year Results
Bank of Cyprus Holdings PLCFull Year Results
Allied Minds PLCFull Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 May 2014 08:34

Thursday broker round-up UPDATE

ASOS: Goldman Sachs reduces target price from 7300p to 6250p, while upgrading to buy. BTG: N+1 Singer shaves target price from 488p to 486p retaining a sell recommendation. EKF Diagnostics: FinnCap initiates with a target price of 38p and a buy recommendation. Exova Group: Credit Suisse starts wi

Read more
20 May 2014 10:08

EKF Diagnostics Subsidiary Signs US Testing Deal As Firm Trades In Line

LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Tuesday its wholly-owned subsidiary, Selah Genomics Inc, has signed a agreement with a US sales firm to provide testing services for a new suite of womaen's health-focused molecular assays. The AIM-listed point-of-care, central labo

Read more
20 May 2014 07:24

UK MORNING BRIEFING: M&A Takes Back Centre Stage

LONDON (Alliance News) - Company acquisitions and disposals have roared back to the fore Tuesday, with RSA Insurance, London Stock Exchange, Wolseley, RPS, Cobham and others all making pre-market announcements

Read more
15 May 2014 10:22

DIRECTOR DEALINGS: EKF Executive Buys 91,000 Shares

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said Michael Bolick, a divisional executive bought 91,00 shares at a price of 27.04 pence per share Monday. Following this transaction, Bolick now holds 5 million shares, which represents 1.17% stake in the firm. Shares in

Read more
8 May 2014 13:31

DIRECTOR DEALINGS: EKF Directors, Non-Executives Buy Shares

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said a group of Directors and non-executives bought shares in the central laboratory and molecular diagnostics business.

Details are as follows.

Read more
7 May 2014 13:10

UK MIDDAY BRIEFING: HSBC Profit Slides, Sainsbury Holding Out

LONDON (Alliance News) - HSBC Holdings Wednesday reported a 20% drop in first-quarter pretax profit, driven by a weak performance Asia, Latin America and its investment bank, that was only partially offset by lower impairment charges and continued cost cutting.

In a

Read more
7 May 2014 12:12

UPDATE: EKF Diagnostics Drops As Medicare Reimbursement For Selah Biomarkers Reduced

LONDON (Alliance News) - EKF Diagnostics Holdings PLC saw its shares drop on the AIM All-Share market Wednesday after the company said reimbursement by Medicare for Selah Genomic's drug metabolism genetic biomarkers panel, has been reduced after revisions by the Medicare Administrative Contractor

Read more
7 May 2014 12:07

UK WINNERS & LOSERS: Legal & General Leads On Confidence In Annuities

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 - WINNERS
-------
Legal & General Group, up 3.2%. The group said it expects to write more

Read more
7 May 2014 09:19

EKF Diagnostics Drops As Medicare Reimbursement For DME Reduced

LONDON (Alliance News) - EKF Diagnostics Holdings PLC saw its shares drop on the AIM All-Share market Wednesday morning as the company said reimbursement by Medicare for Selah Genomic's DME panel, has been reduced after revisions by the MAC. The point-of-care, central laboratory and molecul

Read more
7 May 2014 09:06

UK BROKER RATINGS: UBS Raises Balfour Beatty As Jefferies Cuts

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
BARCLAYS RAISES INTERCONTINENTAL HOTELS PT TO 2100 (1900) PENCE - 'EQUAL WEIGHT
----------
CREDIT SUISSE RAISES IN

Read more
7 May 2014 08:35

Wednesday broker round-up UPDATE

Balfour Beatty: Jefferies reduces target price from 403p to 233p downgrading to hold. Deutsche Bank cuts target price from 280p to 250p and leaves its hold recommendation unchanged. Numis reduces target price to 260p and retains an add rating. Barclays: Deutsche Bank lowers target price from 320p t

Read more
10 Apr 2014 09:56

EKF Diagonostics Raises GBP4 Million In Oversubscribed Share Offer

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said that it had raised GBP4.0 million, before expenses, in an oversubscribed share offer. Last month, the company said it raised GBP22.0 million in a placing at 35 pence a share and said it was also looking to raise an addition

Read more
26 Mar 2014 15:54

Carnival Chairman reduces stake by around a quarter

Micky Arison, the long-standing Chairman of cruise line operator Carnival Corp., docked a batch of shares earlier this week ahead of its better-than-expected first quarter trading update. Arison offloaded 525,348 at $40.09 each, reducing his stake to 104.52m shares. The group on Tuesday reported

Read more
20 Mar 2014 11:46

EKF Diagnostics Raises Funds In Placing As It Announces Acquisitions

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said it has entered into separate conditional agreements to buy US-based molecular diagnostics business Selah Genomics Inc for up to USD70.6 million and Swedish haemoglobin analysers DiaSpect Medical AB for up to GBP20.75 million.

Read more
20 Mar 2014 11:10

EKF Diagnostics proposes acquisition of Selah Genomics and DiaSpect Medical

EKF Diagnostics has entered into conditional agreements to buy US-based Selah Genomics and Swiss firm DiaSpect Medical. The company has proposed raising £22m through the placement of 14,285,714 new ordinary shares and a conditional placing of 48,571,428 new ordinary shares at a placing price of 35p

Read more
891011121314151617

Quickpicks are a member only feature

Login to your account